Chaanakya Capital logoCHAANAKYA CAPITAL

Partners

Neurotech is a team sport. Let's build the bench together.

We work with accelerators, incubators, university tech-transfer offices, fellow investors and business leaders to get the best neurotech companies funded.

Why Chaanakya

  • A specialist second opinion. We help cohort companies pressure-test neurotech science and regulatory plans.

  • On the ground in San Francisco. We host and speak at events where neurotech founders and investors meet. We travel and collaborate internationally.

  • Co-investment opportunities. We share selected deals with partners who bring value to a company.

How to engage

Programs and incubators: email hi@chaanakya.capital about demo days, office hours or cohort referrals. Investors: ask about co-investment opportunities at the same address. Business leaders and MBA professionals: if you're accredited, email hi@chaanakya.capital for the deck, or to ask about our low investment minimums.

Accredited investors only

Rule 506(c) offering

This is a Rule 506(c) offering available only to accredited investors. Accredited investor status must be verified before an investment is accepted.

Investing in private early-stage companies involves substantial risk, including loss of the entire investment, illiquidity, and a long investment horizon. There is no assurance of investment results. Nothing on this website is investment, legal or tax advice.

Chaanakya Capital's offering is made under Rule 506(c) of Regulation D and is open only to accredited investors whose status has been verified. Nothing on this website is an offer to sell, or a solicitation of an offer to buy, any security; any offer is made only through the fund's offering documents. Venture investing is high-risk and illiquid.

¹ Markups are unrealized. They include a personal angel investment made before the fund was formed; positions held by the fund also carry markups. Past performance is not indicative of future results.

Relevant questions